1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,640 | 0,685 | 10:37 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.09. | 2026 Half-Year Results: Theraclion Prepares for a New Stage in Its Development | 627 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive treatment of varicose veins using High-Intensity... ► Artikel lesen | |
| 20.08. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 506 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 23.07. | Theraclion Initiates Its Commercial Momentum in the First Half of 2026 | 686 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 15.07. | Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL | 487 | Business Wire | Regulatory News:
Theraclion (Paris:ALTHE):
Listing venue: Euronext Growth Paris
PEA-PME eligible
ISIN Code: FR0010120402
Website: www.theraclion.com
Under the liquidity contract entrusted... ► Artikel lesen | |
| THERACLION Aktie jetzt für 0€ handeln | |||||
| 09.07. | Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors | 535 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 02.07. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 449 | Business Wire | Article 223-16 Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 18.06. | Theraclion Announces the Evolution of Its Board of Directors | 967 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused... ► Artikel lesen | |
| 08.06. | Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein With AMA CPT Editorial Panel Approval of a New Category III CPT Code | 555 | Business Wire | Regulatory News:
Theraclion (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing a platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the treatment... ► Artikel lesen | |
| 04.06. | Theraclion Announces First Clinical Deployment of Sonovein in Hainan, China | 607 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402 Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the... ► Artikel lesen | |
| 03.06. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 441 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Listed on Euronext Growth Paris
PEA PME eligible
ISIN Code: FR0010120402
Website:... ► Artikel lesen | |
| 01.06. | Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein SpeedPulse Were Presented | 490 | Business Wire | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601718811/en/Illustration of Sonovein with new robotics SpeedPulse
Theraclion... ► Artikel lesen | |
| 11.05. | Theraclion Announces the Strong Success of Its Oversubscribed Capital Increase | 541 | Business Wire | Capital increase of a gross amount of 6 million Issue of 12,484,467 BSA enabling an additional fundraising of 2 million
Regulatory News:
This press release and the information it contains... ► Artikel lesen | |
| 23.04. | XFRA NEW INSTRUMENTS AVAILABLE ON 23.04.2026 | 737 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.04.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.04.2026
Aktien
1 ID1000132806 PT Multi Bintang Indonesia... ► Artikel lesen | |
| 20.04. | Theraclion Announces the Launch of a Capital Increase Through the Issuance of ABSA (Shares With Share Warrants Attached), With Preferential Subscription Rights for Existing Shareholders, for a Gross Amount of €6 Million, Secured by Subscription... | 918 | Business Wire | Subscription price: €0.48 per share, representing a nominal discount of 3.52% to the closing share price as of April 17, 2026, and a discount of 8.60% when taking into account the theoretical... ► Artikel lesen | |
| 16.04. | Theraclion Publishes Its 2025 Financial Results and Provides an Update on Its Outlook | 763 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 29.01. | Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up | 611 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 09.12.25 | Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements | 907 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 29.10.25 | Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results | 700 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 32,620 | +0,06 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| MCKESSON | 857,20 | -1,29 % | McKesson declares $0.94 dividend | ||
| INMODE | 12,335 | +1,19 % | InMode Ltd. - 6-K, Report of foreign issuer | ||
| HCA HEALTHCARE | 401,10 | -0,72 % | HCA Healthcare, Inc. Q3 Sales Increase | WASHINGTON (dpa-AFX) - HCA Healthcare, Inc. (HCA) announced earnings for third quarter of $1.579 billionThe company's bottom line came in at $1.579 billion, or $7.27 per share. This compares... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 525,00 | -0,94 % | Aktien KW 36 Iran, Zinsangst und Trump-"unsinn" bremsen - was wäre wenn? News. Rheinmetall. Vonovia. DEFAMA. Smartbroker. Sino. Trade Republic. Limes Schlosskliniken. Mutares. Symrise. Aroundtown. Enapter. Bilfinger. Nagarro. Haier Smart. Delivery Hero | Aktien - diese Woche im Niemandsland. Positiv am Ende der Woche steht wieder 26 am Anafng des DAX, aber Schwung nach oben fehlt. Impulse hätten Nvidia und die anderen Ki-Aktien mit teilweise beeindruckenden... ► Artikel lesen | |
| BEYOND AIR | 2,170 | 0,00 % | Beyond Air Receives FDA Breakthrough Device Designation for LungFit GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | GARDEN CITY, N.Y., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| HEALTHCARE SERVICES GROUP | 21,800 | 0,00 % | HEALTHCARE SERVICES GROUP INC - 10-Q, Quarterly Report | ||
| ADDUS HOMECARE | 108,00 | 0,00 % | Raymond James startet Coverage für Addus HomeCare mit "Outperform" | ||
| INTERPACE BIOSCIENCES | - | - | Interpace Biosciences, Inc.: Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting | PARSIPPANY, NJ, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCID: IDXG) ("Interpace" or the "Company"), an emerging leader in enabling personalized medicine, today announced that... ► Artikel lesen | |
| MODERN DENTAL | 0,825 | -1,79 % | Modern Dental Group Limited: CICC Initiates Coverage of Modern Dental Group (03600.HK) with Outperform Rating and Target Price of HK$10.0: Accelerating Global Expansion with Digital Efficiency | HONG KONG, Oct 12, 2026 - (ACN Newswire) - CICC initiates coverage on Modern Dental Group (03600.HK) with an 'Outperform' rating and a target price of HK$10.00, highlighting three key drivers. 1) Digitalization-led... ► Artikel lesen | |
| MYOMO | 1,016 | -3,05 % | MYOMO, INC. - S-8, Securities to be offered to employees in employee benefit plans | ||
| IVF HARTMANN | 134,00 | 0,00 % | IVF Hartmann erwirtschaftet im Halbjahr klar mehr Umsatz | Neuhausen am Rheinfall - Der Medizinalbedarf-Hersteller IVF Hartmann hat im ersten Halbjahr 2026 den Umsatz zweistellig gesteigert. Der Gewinn nahm im Vergleich dazu noch deutlicher zu. Die Prognose... ► Artikel lesen | |
| ICU MEDICAL | 149,00 | +1,36 % | Biotech Stocks At 52-Week Highs - Anika Therapeutics & Chemed Corporation Rise With Q2 Results, ICU Medical, Neurocrine Biosciences, Royalty Pharma | LONDON (dpa-AFX) - The following biotech stocks reached a 52-week high on July 29, 2026, driven by key catalysts such as the release of second quarter financial results and ongoing clinical... ► Artikel lesen | |
| HEARTFLOW | 57,82 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,100 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
THERACLION SA gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,031 (+5,35 %) liegt der Kurs bei 0,610 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu THERACLION SA finden Sie auf Wallstreet Online.